Applied MaterialsvsZepp Health

AMAT and ZEPP stock compared: price, dividend, valuation and results, from SEC filings.

AMAT

Applied Materials, Inc.

$302.63

Value $240B

-10.71%
AMAT's page

Applied Materials (AMAT) has a market value of $240B and Zepp Health (ZEPP) $37M. Over the last year, with dividends, AMAT moved +29.6% and ZEPP -90.4%. Dividend yield: AMAT 0.68%, ZEPP none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMAT$240B

    ZEPP$37M

    AMAT is 6,533 times ZEPP

  • Revenue, 12 months

    AMAT$30.8B

    ZEPP$259M

    AMAT is 119 times ZEPP

  • Net income, 12 months

    AMAT$9.3B

    ZEPP-$40M

  • Operating margin

    AMAT29.6%

    ZEPP-11.3%

    40.9 points apart

  • ROIC

    AMAT27.5%

    ZEPP-6.0%

    33.5 points apart

  • P/E

    AMAT25.9

    ZEPP–

  • Dividend yield

    AMAT0.7%

    ZEPP0.0%

    0.7 points apart

  • 5-year return

    AMAT+110.6%

    ZEPP-92.3%

    202.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMAT+110.6%

ZEPP-92.3%

020040020222023202420252026
Returns by period
PeriodAMATWith dividendsZEPPWith dividends
1 year since November 19, 2025+29.6%Price +28.7%-90.4%Price -90.4%
3 years since November 20, 2023+103.4%+26.7% a yearPrice +98.4%-57.2%-24.7% a yearPrice -57.2%
5 years since November 19, 2021+110.6%+16.1% a yearPrice +101.7%-92.3%-40.1% a yearPrice -92.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMATApplied MaterialsZEPPZepp Health

Valuation

AMATZEPP
Valuation
Price$302.63$2.31
Market value$240B$37M
Enterprise value (EV)$237B$151M
P/E25.9–
P/E, 5-year median21.4–
P/B9.40.2
EV/EBIT26.0–
Free cash flow yield2.3%–

Results and growth

AMATZEPP
Results and growth
Revenue, 12 months$30.8B$259M
Net income, 12 months$9.3B-$40M
Free cash flow, 12 months$5.6B-$26M
Earnings per share, 12 months$11.59-$2.56
Revenue growth, year on year4.4%41.8%
Revenue growth a year, past+10.5%over 5 years-23.5%over 5 years
EPS growth a year, past+17.2%over 5 years–

Margins and returns on capital

AMATZEPP
Margins and returns on capital
Gross margin49.4%38.3%
Operating margin29.6%-11.3%
Net margin30.0%-15.5%
ROIC27.5%-6.0%
ROE41.7%-18.7%

Balance sheet

AMATZEPP
Balance sheet
Cash$9.2B$57M
Total debt$7.3B$173M
Net debt / EBITDA-0.3–
Interest cover33.0×-5.1×

Dividends and buybacks

AMATZEPP
Dividends and buybacks
Dividend yield0.7%–
Dividend per share, 12 months$2.05–
Dividend growth a year, past+15.4%over 5 years–
Buyback yield2.0%3.4%
Shareholder yield2.7%3.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMAT or ZEPP

Didn't find what you were looking for?

Ask us
Which is bigger, Applied Materials or Zepp Health?

By market value, Applied Materials ($240B) is about 6,532.7 times Zepp Health ($37M), at today's prices.

How did AMAT and ZEPP stock do over the last 5 years?

Since November 19, 2021, AMAT's price moved +101.7% and ZEPP's -92.5%. With dividends: AMAT +110.6% (+16.1% a year), ZEPP -92.3% (-40.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMAT or ZEPP?

The dividend yield at today's price is 0.68% for Applied Materials and none for Zepp Health. Over the last twelve months they paid $2.05 and – per share.

Which has the higher profit margins, Applied Materials or Zepp Health?

Over the last twelve months, the net margin was 30.0% for Applied Materials and -15.5% for Zepp Health, and the operating margin 29.6% and -11.3%. Revenue was $30.8B and $259M.

Which is the better investment, Applied Materials or Zepp Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.